{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T01:54:56Z","timestamp":1648864496723},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00120-019-0973-7","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T14:05:54Z","timestamp":1561471554000},"page":"774-780","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molekulares Tumorboard Peniskarzinom \u2013 eine Herausforderung"],"prefix":"10.1007","volume":"58","author":[{"given":"C.","family":"Protzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. W.","family":"Hakenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"issue":"2","key":"973_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.euo.2018.07.010","volume":"2","author":"S Davidsson","year":"2019","unstructured":"Davidsson S, Carlsson J, Giunchi F, Harlow A, Kirrander P, Rider J, Fiorentino M, Andr\u00e9n O (2019) PD-L1\u00a0expression in men with\u00a0penile cancer\u00a0and its association with clinical outcomes. Eur Urol Oncol 2(2):214\u2013221","journal-title":"Eur Urol Oncol."},{"key":"973_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics. Ca Cancer J Clin 57:43\u201366","journal-title":"Ca Cancer J Clin"},{"issue":"1","key":"973_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"OW Hakenberg","year":"2015","unstructured":"Hakenberg OW, Comp\u00e9rat EM, Minhas S, Necchi A, Protzel C, Watkin N (2015) EAU Guidelines on penile cancer: 2014 update. Eur Urol 67(1):142\u2013150","journal-title":"Eur Urol"},{"issue":"4","key":"973_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00428-014-1548-z","volume":"464","author":"Ch Kakies","year":"2014","unstructured":"Kakies Ch, Lopez-Beltran A, Comperat E, Erbersdobler A, Grobholz R, Hakenberg OW, Hartmann A, Horn LC, H\u00f6hn AK, K\u00f6llermann J, Kristiansen G, Montironi R, Scarpelli M, Protzel C (2014) Reproducibility of histopathologic tumor grading in penile cancer\u2014results of a\u00a0European project. Virchows Arch 464(4):453\u2013456","journal-title":"Virchows Arch"},{"issue":"8","key":"973_CR5","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.humpath.2010.11.010","volume":"42","author":"S Maier","year":"2011","unstructured":"Maier S, Wilbertz T, Braun M, Scheble V, Reischl M, Mikut R, Menon R, Nikolov P, Petersen K, Beschorner C, Moch H, Kakies C, Protzel C, Bauer J, Soltermann A, Fend F, Staebler A, Lengerke C, Perner S (2011) SOX2 amplification is a\u00a0common event in squamous cell carcinomas of different organ sites. Hum Pathol 42(8):1078\u20131088","journal-title":"Hum Pathol"},{"key":"973_CR6","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00428-010-1007-4","volume":"458","author":"M Poetsch","year":"2011","unstructured":"Poetsch M, Hemmerich M, Kakies C et\u00a0al (2011) Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas. Virchows Arch 458:221\u2013229","journal-title":"Virchows Arch"},{"key":"973_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0022-5347(18)38409-X","volume":"171","author":"C Protzel","year":"2004","unstructured":"Protzel C, Knoedel JE, Zimmermann U, Klebingat KJ, Giebel J, Woenckhaus C (2004) Strong expression of proliferation marker Ki67 predicts lymph node metastasis in patients with penile cancer. J\u00a0Urol 171:309","journal-title":"J Urol"},{"key":"973_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00428-008-0590-0","volume":"452","author":"C Protzel","year":"2008","unstructured":"Protzel C, Kakies C, Kleist B, Poetsch M, Giebel J (2008) Down-regulation of the metastasis suppressor protein KAI1\/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma. Virchows Arch 452:369\u2013375","journal-title":"Virchows Arch"},{"key":"973_CR9","first-page":"202","volume":"181","author":"C Protzel","year":"2009","unstructured":"Protzel C, Kakies C, Poetsch M, Giebel J, Wolf E, Hakenberg OW (2009) Down-Regulation of metastasis suppressor gene nm23-H1 correlates with the occurence of metastases and poor prognosis in penile squamous cell carcinoma. J\u00a0Urol 181:202","journal-title":"J Urol"},{"key":"973_CR10","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/modpathol.3800931","volume":"20","author":"M Poetsch","year":"2007","unstructured":"Poetsch M, Schuart BJ, Schwesinger G, Kleist B, Protzel C (2007) Screening of microsatellite markers in penile cancer reveals differences between metastatic and nonmetastatic carcinomas. Mod Pathol 20:1069\u20131077","journal-title":"Mod Pathol"},{"issue":"2","key":"973_CR11","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.juro.2016.01.115","volume":"196","author":"JM Hartz","year":"2016","unstructured":"Hartz JM, Engelmann D, F\u00fcrst K, Marquardt S, Spitschak A, Goody D, Protzel C, Hakenberg OW, P\u00fctzer BM (2016) Integrated loss of miR-1\/miR-101\/miR-204 discriminates metastatic from nonmetastatic penile carcinomas and Can predict patient outcome. J\u00a0Urol 196(2):570\u2013578","journal-title":"J Urol"},{"issue":"3","key":"973_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00345-010-0575-x","volume":"29","author":"C Protzel","year":"2011","unstructured":"Protzel C, Richter M, Poetsch M et\u00a0al (2011) The role of annexins I, II and IV in tumor development, progression and metastasis of human penile squamous cell carcinomas. World J Urol 29(3):393\u2013398","journal-title":"World J Urol"},{"issue":"10","key":"973_CR13","doi-asserted-by":"publisher","first-page":"433.e19","DOI":"10.1016\/j.urolonc.2016.05.015","volume":"34","author":"IW da Cunha","year":"2016","unstructured":"da Cunha IW, Souza MJ, da Costa WH, Am\u00e2ncio AM, Fonseca FP, Zequi Sde C, Lopes A, Guimar\u00e3es GC, Soares F (2016) Epithelial-mesenchymal transition (EMT) phenotype at invasion front of squamous cell carcinoma of the penis influences oncological outcomes. Urol Oncol 34(10):433.e19\u2013433.e26","journal-title":"Urol Oncol"},{"issue":"4","key":"973_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.euf.2017.02.009","volume":"4","author":"F Fenner","year":"2018","unstructured":"Fenner F, Goody D, Protzel C, Erbersdobler A, Richter C, Hartz JM, Naumann CM, Kalthoff H, Herchenr\u00f6der O, Hakenberg OW, P\u00fctzer BM (2018) E2F1 signalling is predictive of chemoresistance and Lymphogenic metastasis in penile cancer: a pilot functional study reveals new prognostic biomarkers. Eur Urol Focus 4(4):599\u2013607","journal-title":"Eur Urol Focus"},{"issue":"5","key":"973_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.clgc.2016.01.013","volume":"14","author":"TB Dorff","year":"2016","unstructured":"Dorff TB, Schuckman AK, Schwartz R, Rashad S, Bulbul A, Cai J, Pinski J, Ma Y, Danenberg K, Skinner E, Quinn DI (2016) Epidermal growth factor receptor, excision-repair cross-complementation group 1 protein, and thymidylate synthase expression in\u00a0penile cancer. Clin Genitourin Cancer 14(5):450\u2013456","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"973_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00345-015-1593-5","volume":"34","author":"K Zargar-Shoshtari","year":"2016","unstructured":"Zargar-Shoshtari K, Sharma P, Djajadiningrat R, Catanzaro M, Ye DW, Zhu Y, Nicolai N, Horenblas S, Spiess PE (2016) Extent of pelvic lymph node dissection in penile cancer may impact survival. World J Urol 34(3):353\u2013359","journal-title":"World J Urol"},{"issue":"3","key":"973_CR17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.juro.2015.03.090","volume":"194","author":"K Zargar-Shoshtari","year":"2015","unstructured":"Zargar-Shoshtari K, Djajadiningrat R, Sharma P, Catanzaro M, Zhu Y, Nicolai N, Horenblas S, Spiess P (2015) Establishing Criteria for bilateral pelvic lymph node dissection in the management of penile cancer: Lesson learned from an international study. J\u00a0Urol 194(3):696\u2013701","journal-title":"J Urol"},{"issue":"4","key":"973_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.juro.2013.10.140","volume":"191","author":"G Lughezzani","year":"2014","unstructured":"Lughezzani G, Catanzaro M, Torelli T, Piva L, Biasoni D, Stagni S, Crestani A, Guttilla A, Raggi D, Giannatempo P, Necchi A, Pizzocaro G, Colecchia M, Salvioni R, Nicolai N (2014) J\u00a0Urol 191(4):977\u2013982","journal-title":"J Urol"},{"issue":"3","key":"973_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/bju.14013","volume":"121","author":"A Necchi","year":"2018","unstructured":"Necchi A, Lo Vullo S, Perrone F, Raggi D, Giannatempo P, Calareso G, Nicolai N, Piva L, Biasoni D, Catanzaro M, Torelli T, Stagni S, Togliardi E, Colecchia M, Busico A, Gloghini A, Testi A, Mariani L, Salvioni R (2018) First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic\u00a0penile\u00a0squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study. BJU Int 121(3):348\u2013356","journal-title":"BJU Int"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-019-0973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-019-0973-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-019-0973-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T23:33:24Z","timestamp":1592955204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-019-0973-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1007\/s00120-019-0973-7","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"25 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Protzel und O.W.\u00a0Hakenberg geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}